Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 22, 2015Journal of Clinical InvestigationOpen Access

RASA3 is a critical inhibitor of RAP1-dependent platelet activation

View Full Paper
Ask AI
Bookmark
Share

Authors

LSLucia StefaniniDPDavid S. PaulRRRaymond F. Robledo

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Stefanini et al. (2015) studied this question.

synapsesocial.com/papers/6a94331a2167e799456d346dhttps://doi.org/10.1172/jci77993
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways2012 · 795 citations
  2. 2A Key Role of Adenosine Diphosphate in the Irreversible Platelet Aggregation Induced by the PAR1-Activating Peptide Through the Late Activation of Phosphoinositide 3-Kinase1999 · 214 citations
  3. 3P2Y <sub>12</sub> Antagonism2008 · 108 citations
  4. 4A talin mutant that impairs talin-integrin binding in platelets decelerates αIIbβ3 activation without pathological bleeding2014 · 49 citations
  5. 5Rap1GAP2 is a new GTPase-activating protein of Rap1 expressed in human platelets2005 · 103 citations